Skip to main content
. 2022 Jun 14;10(6):1410. doi: 10.3390/biomedicines10061410

Figure 2.

Figure 2

Schematic illustration of immune checkpoint inhibitor mechanism of action. Monoclonal antibodies, such as those targeting PD1/PDL-1, CTLA-4, and TIM3, block key immune checkpoint molecules typically expressed on AML blasts for the purpose of immune evasion. Image created with Biorender.com (accessed on 17 May 2022).